Aardvark Therapeutics Stock
HealthTechLooking to sell Aardvark Therapeutics stock or options?
Aardvark Therapeutics is focused on developing small molecule therapeutics aimed at treating obesity and rare genetic metabolic disorders. Their innovative therapeutics provide a pioneering oral formulation that precisely disrupts hunger signaling while maintaining energy balance, without affecting nutrient absorption. This approach equips healthcare providers with a safe and efficacious treatment option for diseases associated with obesity.
Decheng Capital, SilverArc Capital Management, Vickers Venture Partners, Cantor Fitzgerald, Gershon Capital, Tetragon Financial Group, LG Technology Ventures, FPWR, Laurion Capital Management, Cormorant Asset Management, Prader-Willi Syndrome Association, SymBiosis Capital Management, Sorrento Therapeutics, Premier Partners, BNH Investment, Dreavent, Walleye Capital, Surveyor Capital.